• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

argenx

Green light double green light approval approvals FDA FDA nod
Pharma

AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nods

Continuing to harvest a bounty approvals, AZ scored nods for its C5 inhibitor to treat generalized myasthenia gravis on both sides of the Atlantic.
Fraiser Kansteiner Nov 16, 2026 10:39am
shadow follow leader

Argenx reports Q3 sales bump and a new trial requirement

Oct 23, 2026 11:42am
Argenx

Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial

Oct 8, 2026 10:44am
Argenx

Argenx preps next potential Vyvgart nod after ph. 3 win

Aug 17, 2026 10:52am
Imaavy

J&J data set up Imaavy for expansion to treat anemic disorder

Jun 11, 2026 10:36am
Collage poster study of businessmen picture chart arrow goes up

Orphan drug sales to surge past $400B in 2032: report

Mar 12, 2026 8:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings